Antimicrobial peptides: an alternative for innovative medicines?

Verfasser / Beitragende:
[João da Costa, Marta Cova, Rita Ferreira, Rui Vitorino]
Ort, Verlag, Jahr:
2015
Enthalten in:
Applied Microbiology and Biotechnology, 99/5(2015-03-01), 2023-2040
Format:
Artikel (online)
ID: 605504253
LEADER caa a22 4500
001 605504253
003 CHVBK
005 20210128100615.0
007 cr unu---uuuuu
008 210128e20150301xx s 000 0 eng
024 7 0 |a 10.1007/s00253-015-6375-x  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00253-015-6375-x 
245 0 0 |a Antimicrobial peptides: an alternative for innovative medicines?  |h [Elektronische Daten]  |c [João da Costa, Marta Cova, Rita Ferreira, Rui Vitorino] 
520 3 |a Antimicrobial peptides are small molecules with activity against bacteria, yeasts, fungi, viruses, bacteria, and even tumor cells that make these molecules attractive as therapeutic agents. Due to the alarming increase of antimicrobial resistance, interest in alternative antimicrobial agents has led to the exploitation of antimicrobial peptides, both synthetic and from natural sources. Thus, many peptide-based drugs are currently commercially available for the treatment of numerous ailments, such as hepatitis C, myeloma, skin infections, and diabetes. Initial barriers are being increasingly overcome with the development of cost-effective, more stable peptides. Herein, we review the available strategies for their synthesis, bioinformatics tools for the rational design of antimicrobial peptides with enhanced therapeutic indices, hurdles and shortcomings limiting the large-scale production of AMPs, as well as the challenges that the pharmaceutical industry faces on their use as therapeutic agents. 
540 |a Springer-Verlag Berlin Heidelberg, 2015 
690 7 |a Salivary peptide  |2 nationallicence 
690 7 |a Antitumoral  |2 nationallicence 
690 7 |a Synthesis  |2 nationallicence 
690 7 |a Bioinformatics  |2 nationallicence 
700 1 |a da Costa  |D João  |u Mass Spectrometry Centre, QOPNA, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal  |4 aut 
700 1 |a Cova  |D Marta  |u Mass Spectrometry Centre, QOPNA, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal  |4 aut 
700 1 |a Ferreira  |D Rita  |u Mass Spectrometry Centre, QOPNA, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal  |4 aut 
700 1 |a Vitorino  |D Rui  |u Mass Spectrometry Centre, QOPNA, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal  |4 aut 
773 0 |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/5(2015-03-01), 2023-2040  |x 0175-7598  |q 99:5<2023  |1 2015  |2 99  |o 253 
856 4 0 |u https://doi.org/10.1007/s00253-015-6375-x  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a review-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00253-015-6375-x  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a da Costa  |D João  |u Mass Spectrometry Centre, QOPNA, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cova  |D Marta  |u Mass Spectrometry Centre, QOPNA, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ferreira  |D Rita  |u Mass Spectrometry Centre, QOPNA, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Vitorino  |D Rui  |u Mass Spectrometry Centre, QOPNA, Department of Chemistry, University of Aveiro, 3810-193, Aveiro, Portugal  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/5(2015-03-01), 2023-2040  |x 0175-7598  |q 99:5<2023  |1 2015  |2 99  |o 253